Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Eziem D
- Development stage
- Unknown
- Lead developer
- San Fegan Biotech
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Eziem D is a fixed-dose combination medication developed and marketed by San Fegan Biotech, an Indian pharmaceutical company. It is primarily indicated for the treatment of gastrointestinal and hepatological conditions, specifically those involving acid reflux and impaired gastric motility. The product contains two active ingredients: esomeprazole (20 mg), a proton pump inhibitor that reduces gastric acid secretion by inhibiting the H+/K+ ATPase enzyme, and domperidone (30 mg), a dopamine D2 receptor antagonist that acts as a prokinetic agent to enhance gastrointestinal transit. Eziem D is available in capsule form, including a sustained-release (SR) version designed for prolonged therapeutic effect.
- Brand names
- Eziem D
- Other names
- Eziem-D CapsuleEziem-D Capsule SR
02
Targets
DRD2 (Dopamine D2 Receptor)ATP4A (Potassium–transporting ATPase alpha chain 1)
Beyond the preview
Go deeper on Eziem D.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Eziem D.